Lassa fever treatment with antiviral combinations
Treatments studied
Part of Infections clinical trials.
This trial tests different combinations of antiviral drugs (favipiravir, ribavirin, and a steroid called dexamethasone) in adults hospitalized with Lassa fever. The goal is to find the safest and most effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood test that confirmed Lassa fever
- You are sick enough to need hospital care
- You are 18 or older (or 12+ for some parts of the study)
- You have not already been treated for Lassa fever (except support care)
- You are not pregnant and have no allergy to the study drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding dexamethasone, a steroid that reduces inflammation, to standard care can help people with severe Lassa fever. It is for adults who are very sick with confirmed Lassa fever.
This trial tests an investigational vaccine to prevent Lassa fever, a serious illness found in parts of West Africa. People in different age groups will get the vaccine or a placebo and be followed to see if it’s safe and helps the immune system respond.
This trial tests different experimental drugs to treat dengue early. It aims to find which treatment works best and is safe for patients who start within 48 hours of fever.
This trial tests if antiviral medications can help adults with early respiratory syncytial virus (RSV) feel better faster. It is for people aged 18 to 64 who have had RSV symptoms for 4 days or less and have tested positive for the virus.
This study checks a new, faster test for Ebola and Lassa viruses using stored blood samples from past infections. It compares the new test's results with the original diagnosis to see if the quick test is accurate.
This trial tests different treatments for Crimean-Congo hemorrhagic fever (CCHF), a serious viral infection. It aims to find which treatment is safe and works best for patients who are hospitalized with the disease.
Hear when a new Lassa Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.